Literature DB >> 3782096

Cytochalasin B enhancement of the diacylglycerol response in formyl peptide-stimulated neutrophils.

P J Honeycutt, J E Niedel.   

Abstract

Diacylglycerol has gained wide acceptance as an important second messenger in the signal transduction mechanism by which occupancy of certain membrane receptors such as the formyl peptide receptor of neutrophils leads to biological responses, but supporting evidence for this proposed role is limited. We have utilized a recently developed diacylglycerol kinase assay (Preiss, J. E., Loomis, C. R., Bishop, W. R., Stein, R., Niedel, J. E., and Bell, R. M. (1986) J. Biol. Chem. 261, 8597-8600) to characterize the diacylglycerol response of normal human neutrophils stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLP) and other formyl peptides. fMLP alone stimulated a slow, prolonged 36% rise in diacylglycerol levels above basal levels. Cytochalasin B enhances several fMLP-stimulated neutrophil responses, including aggregation, superoxide production, and degranulation. Pretreatment of neutrophils with cytochalasin B markedly increased the rate and extent of the diacylglycerol response to fMLP stimulation. Diacylglycerol peaked at 5 min at 206 +/- 21% above basal levels with a t1/2 of 45 s. The diacylglycerol response was time- and fMLP and cytochalasin B concentration-dependent, appropriate for the known biological activities of several peptide analogues, and completely inhibited by pretreatment with pertussis toxin. These data demonstrate that diacylglycerol may function as a second messenger for neutrophil activation and suggest that cytochalasin B enhancement of neutrophil biology may be the result of an enhanced diacylglycerol response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782096

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Neisseria gonorrhoeae porin modifies the oxidative burst of human professional phagocytes.

Authors:  D R Lorenzen; D Günther; J Pandit; T Rudel; E Brandt; T F Meyer
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Involvement of GTP-binding proteins in actin polymerization in human neutrophils.

Authors:  T Bengtsson; E Särndahl; O Stendahl; T Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 3.  Reactive oxygen species in phagocytic leukocytes.

Authors:  John M Robinson
Journal:  Histochem Cell Biol       Date:  2008-07-03       Impact factor: 4.304

4.  Quantification of contributions of phospholipid precursors to diradylglycerols in stimulated mononuclear phagocytes.

Authors:  R J Sebaldt; D O Adams; R J Uhing
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

5.  Changes in inositol 1,4,5-trisphosphate mass in agonist-stimulated human neutrophils.

Authors:  D A Fruman; D A Gamache; M J Ernest
Journal:  Agents Actions       Date:  1991-09

6.  Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes.

Authors:  G Rothe; A Oser; G Valet
Journal:  Naturwissenschaften       Date:  1988-07

Review 7.  Activation of the neutrophil respiratory burst by chemoattractants: regulation of the N-formyl peptide receptor in the plasma membrane.

Authors:  A J Jesaitis; R A Allen
Journal:  J Bioenerg Biomembr       Date:  1988-12       Impact factor: 2.945

8.  Cell-shape-associated transcriptional activation of the p52(PAI-1) gene in rat kidney cells.

Authors:  P J Higgins; M P Ryan; A Ahmed
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

9.  Leukocyte chemoattraction by 1,2-diacylglycerol.

Authors:  T M Wright; R D Hoffman; J Nishijima; L Jakoi; R Snyderman; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  Inhibition by gomisin C (a lignan from Schizandra chinensis) of the respiratory burst of rat neutrophils.

Authors:  J P Wang; S L Raung; M F Hsu; C C Chen
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.